Frontiers in Fontan failure: Innovation and improving outcomes: A conference summary

Georges Ephrem, Camden Hebson, Anitha John, Estella Moore, Maan Jokhadar, Ryan Ford, Gruschen Veldtman, Yoav Dori, Michelle Gurvitz, Brian Kogon, Adrienne Kovacs, Meghan Roswick, Michael McConnell, Wendy M. Book, Fred Rodriguez

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The initial “Frontiers in Fontan Failure” conference in 2015 in Atlanta, GA, provided an opportunity for experts in the field of pediatric cardiology and adult congenital heart disease to focus on the etiology, physiology, and potential interventions for patients with “Failing Fontan” physiology. Four types of “Fontan Failure” were described and then published by Dr Book et al. The acknowledgment that even Dr Fontan himself realized that the Fontan procedure “imposed a gradually declining functional capacity and premature late death after an initial period of often excellent palliation.” The purpose of the second “Frontiers in Fontan Failure” was to further the discussion regarding new data and technologies as well as novel interventions. The 2017 “Frontiers in Fontan Failure: Innovation and Improving Outcomes” was sponsored by Children's Healthcare of Atlanta, Sibley Heart Center Cardiology, and Emory University School of Medicine. Future directions in the management of Fontan failure include further investigations into the risk of sudden cardiac death and how to properly prevent it, achievable interventions in modifying the Fontan physiology to treat or prevent late complications, and improved and refined algorithms in Fontan surveillance. Finally, further research into the interventional treatment of lymphatic-related complications hold the promise of marked improvement in the quality of life of advanced Fontan failure patients and as such should be encouraged and contributed to.

Original languageEnglish (US)
JournalCongenital Heart Disease
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Cardiology
Fontan Procedure
Premature Mortality
Sudden Cardiac Death
Heart Diseases
Quality of Life
Medicine
Pediatrics
Technology
Delivery of Health Care
Research
Therapeutics
Direction compound

Keywords

  • failure
  • Fontan
  • innovation
  • outcomes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Ephrem, G., Hebson, C., John, A., Moore, E., Jokhadar, M., Ford, R., ... Rodriguez, F. (Accepted/In press). Frontiers in Fontan failure: Innovation and improving outcomes: A conference summary. Congenital Heart Disease. https://doi.org/10.1111/chd.12685

Frontiers in Fontan failure : Innovation and improving outcomes: A conference summary. / Ephrem, Georges; Hebson, Camden; John, Anitha; Moore, Estella; Jokhadar, Maan; Ford, Ryan; Veldtman, Gruschen; Dori, Yoav; Gurvitz, Michelle; Kogon, Brian; Kovacs, Adrienne; Roswick, Meghan; McConnell, Michael; Book, Wendy M.; Rodriguez, Fred.

In: Congenital Heart Disease, 01.01.2018.

Research output: Contribution to journalArticle

Ephrem, G, Hebson, C, John, A, Moore, E, Jokhadar, M, Ford, R, Veldtman, G, Dori, Y, Gurvitz, M, Kogon, B, Kovacs, A, Roswick, M, McConnell, M, Book, WM & Rodriguez, F 2018, 'Frontiers in Fontan failure: Innovation and improving outcomes: A conference summary', Congenital Heart Disease. https://doi.org/10.1111/chd.12685
Ephrem, Georges ; Hebson, Camden ; John, Anitha ; Moore, Estella ; Jokhadar, Maan ; Ford, Ryan ; Veldtman, Gruschen ; Dori, Yoav ; Gurvitz, Michelle ; Kogon, Brian ; Kovacs, Adrienne ; Roswick, Meghan ; McConnell, Michael ; Book, Wendy M. ; Rodriguez, Fred. / Frontiers in Fontan failure : Innovation and improving outcomes: A conference summary. In: Congenital Heart Disease. 2018.
@article{a442e4632769491394707a8151398bd4,
title = "Frontiers in Fontan failure: Innovation and improving outcomes: A conference summary",
abstract = "The initial “Frontiers in Fontan Failure” conference in 2015 in Atlanta, GA, provided an opportunity for experts in the field of pediatric cardiology and adult congenital heart disease to focus on the etiology, physiology, and potential interventions for patients with “Failing Fontan” physiology. Four types of “Fontan Failure” were described and then published by Dr Book et al. The acknowledgment that even Dr Fontan himself realized that the Fontan procedure “imposed a gradually declining functional capacity and premature late death after an initial period of often excellent palliation.” The purpose of the second “Frontiers in Fontan Failure” was to further the discussion regarding new data and technologies as well as novel interventions. The 2017 “Frontiers in Fontan Failure: Innovation and Improving Outcomes” was sponsored by Children's Healthcare of Atlanta, Sibley Heart Center Cardiology, and Emory University School of Medicine. Future directions in the management of Fontan failure include further investigations into the risk of sudden cardiac death and how to properly prevent it, achievable interventions in modifying the Fontan physiology to treat or prevent late complications, and improved and refined algorithms in Fontan surveillance. Finally, further research into the interventional treatment of lymphatic-related complications hold the promise of marked improvement in the quality of life of advanced Fontan failure patients and as such should be encouraged and contributed to.",
keywords = "failure, Fontan, innovation, outcomes",
author = "Georges Ephrem and Camden Hebson and Anitha John and Estella Moore and Maan Jokhadar and Ryan Ford and Gruschen Veldtman and Yoav Dori and Michelle Gurvitz and Brian Kogon and Adrienne Kovacs and Meghan Roswick and Michael McConnell and Book, {Wendy M.} and Fred Rodriguez",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/chd.12685",
language = "English (US)",
journal = "Congenital Heart Disease",
issn = "1747-079X",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Frontiers in Fontan failure

T2 - Innovation and improving outcomes: A conference summary

AU - Ephrem, Georges

AU - Hebson, Camden

AU - John, Anitha

AU - Moore, Estella

AU - Jokhadar, Maan

AU - Ford, Ryan

AU - Veldtman, Gruschen

AU - Dori, Yoav

AU - Gurvitz, Michelle

AU - Kogon, Brian

AU - Kovacs, Adrienne

AU - Roswick, Meghan

AU - McConnell, Michael

AU - Book, Wendy M.

AU - Rodriguez, Fred

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The initial “Frontiers in Fontan Failure” conference in 2015 in Atlanta, GA, provided an opportunity for experts in the field of pediatric cardiology and adult congenital heart disease to focus on the etiology, physiology, and potential interventions for patients with “Failing Fontan” physiology. Four types of “Fontan Failure” were described and then published by Dr Book et al. The acknowledgment that even Dr Fontan himself realized that the Fontan procedure “imposed a gradually declining functional capacity and premature late death after an initial period of often excellent palliation.” The purpose of the second “Frontiers in Fontan Failure” was to further the discussion regarding new data and technologies as well as novel interventions. The 2017 “Frontiers in Fontan Failure: Innovation and Improving Outcomes” was sponsored by Children's Healthcare of Atlanta, Sibley Heart Center Cardiology, and Emory University School of Medicine. Future directions in the management of Fontan failure include further investigations into the risk of sudden cardiac death and how to properly prevent it, achievable interventions in modifying the Fontan physiology to treat or prevent late complications, and improved and refined algorithms in Fontan surveillance. Finally, further research into the interventional treatment of lymphatic-related complications hold the promise of marked improvement in the quality of life of advanced Fontan failure patients and as such should be encouraged and contributed to.

AB - The initial “Frontiers in Fontan Failure” conference in 2015 in Atlanta, GA, provided an opportunity for experts in the field of pediatric cardiology and adult congenital heart disease to focus on the etiology, physiology, and potential interventions for patients with “Failing Fontan” physiology. Four types of “Fontan Failure” were described and then published by Dr Book et al. The acknowledgment that even Dr Fontan himself realized that the Fontan procedure “imposed a gradually declining functional capacity and premature late death after an initial period of often excellent palliation.” The purpose of the second “Frontiers in Fontan Failure” was to further the discussion regarding new data and technologies as well as novel interventions. The 2017 “Frontiers in Fontan Failure: Innovation and Improving Outcomes” was sponsored by Children's Healthcare of Atlanta, Sibley Heart Center Cardiology, and Emory University School of Medicine. Future directions in the management of Fontan failure include further investigations into the risk of sudden cardiac death and how to properly prevent it, achievable interventions in modifying the Fontan physiology to treat or prevent late complications, and improved and refined algorithms in Fontan surveillance. Finally, further research into the interventional treatment of lymphatic-related complications hold the promise of marked improvement in the quality of life of advanced Fontan failure patients and as such should be encouraged and contributed to.

KW - failure

KW - Fontan

KW - innovation

KW - outcomes

UR - http://www.scopus.com/inward/record.url?scp=85055261194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055261194&partnerID=8YFLogxK

U2 - 10.1111/chd.12685

DO - 10.1111/chd.12685

M3 - Article

C2 - 30343507

AN - SCOPUS:85055261194

JO - Congenital Heart Disease

JF - Congenital Heart Disease

SN - 1747-079X

ER -